Dolby Laboratories Stock Forecast, Price & News

Dolby Laboratories' stock was trading at $60.23 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, DLB shares have increased by 7.8% and is now trading at $64.90.
View which stocks have been most impacted by COVID-19.

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Dolby Laboratories in the last year. There are currently 1 hold rating and 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Dolby Laboratories.

Dolby Laboratories is scheduled to release its next quarterly earnings announcement on Thursday, November 12th 2020.
View our earnings forecast for Dolby Laboratories.

Dolby Laboratories, Inc. (NYSE:DLB) announced its earnings results on Monday, August, 3rd. The electronics maker reported $0.86 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $0.13 by $0.73. The electronics maker earned $246.91 million during the quarter, compared to analyst estimates of $232.61 million. Dolby Laboratories had a net margin of 20.89% and a return on equity of 10.67%. Dolby Laboratories's revenue for the quarter was down 18.3% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.76 earnings per share.
View Dolby Laboratories' earnings history.

Dolby Laboratories announced a quarterly dividend on Tuesday, August 4th. Investors of record on Monday, August 17th will be paid a dividend of $0.22 per share on Wednesday, August 26th. This represents a $0.88 annualized dividend and a yield of 1.36%. The ex-dividend date of this dividend is Friday, August 14th.
View Dolby Laboratories' dividend history.

Dolby Laboratories updated its fourth quarter earnings guidance on Monday, August, 3rd. The company provided earnings per share (EPS) guidance of $0.22-0.37 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $0.42. The company issued revenue guidance of $225-255 million, compared to the consensus revenue estimate of $251.94 million.

5 brokers have issued 1 year price targets for Dolby Laboratories' stock. Their forecasts range from $65.00 to $83.00. On average, they expect Dolby Laboratories' share price to reach $73.67 in the next year. This suggests a possible upside of 13.5% from the stock's current price.
View analysts' price targets for Dolby Laboratories.

Some companies that are related to Dolby Laboratories include Amphenol (APH), Corning (GLW), Littelfuse (LFUS), Vishay Intertechnology (VSH) and Rogers (ROG).
View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Dolby Laboratories investors own include InterDigital Wireless (IDCC), Advanced Micro Devices (AMD), Energy Transfer LP Unit (ET), AbbVie (ABBV), Abbott Laboratories (ABT), Bank of Hawaii (BOH), Mastercard (MA), Stag Industrial (STAG), Comcast (CMCSA) and NVIDIA (NVDA).

Dolby Laboratories trades on the New York Stock Exchange (NYSE) under the ticker symbol "DLB."

Dolby Laboratories' stock is owned by a number of retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (5.86%), Ceredex Value Advisors LLC (1.25%), Bank of New York Mellon Corp (1.12%), Bank of Montreal Can (0.96%), Nantahala Capital Management LLC (0.92%) and Blair William & Co. IL (0.86%). Company insiders that own Dolby Laboratories stock include Avadis Tevanian, Dagmar Dolby, Ed H Bowman Jr, Giles Baker, Kevin J Yeaman, Lewis Chew, Mark Andrew Sherman, Peter C Gotcher, Ryan Nicholson, Steven E Forshay and Todd Pendleton.
View institutional ownership trends for Dolby Laboratories.

DLB stock was sold by a variety of institutional investors in the last quarter, including Blair William & Co. IL, Thrivent Financial for Lutherans, First Trust Advisors LP, Nuveen Asset Management LLC, Canada Pension Plan Investment Board, Bank of America Corp DE, Vanguard Group Inc., and Bank of Montreal Can. Company insiders that have sold Dolby Laboratories company stock in the last year include Avadis Tevanian, Giles Baker, Kevin J Yeaman, Lewis Chew, Mark Andrew Sherman, Steven E Forshay, and Todd Pendleton.
View insider buying and selling activity for Dolby Laboratories.

DLB stock was acquired by a variety of institutional investors in the last quarter, including Bank of New York Mellon Corp, Kayne Anderson Rudnick Investment Management LLC, Alyeska Investment Group L.P., KAMES CAPITAL plc, Marathon Asset Management LLP, Ceredex Value Advisors LLC, Obermeyer Wood Investment Counsel Lllp, and Seizert Capital Partners LLC.
View insider buying and selling activity for Dolby Laboratories.

Shares of DLB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of DLB stock can currently be purchased for approximately $64.90.

Dolby Laboratories has a market capitalization of $6.53 billion and generates $1.24 billion in revenue each year. The electronics maker earns $255.15 million in net income (profit) each year or $2.44 on an earnings per share basis. Dolby Laboratories employs 2,193 workers across the globe.

The official website for Dolby Laboratories is www.dolby.com.

Dolby Laboratories' mailing address is 1275 MARKET STREET, SAN FRANCISCO CA, 94103. The electronics maker can be reached via phone at 415-558-0200 or via email at [email protected]